Health Catalyst, Inc. (HCAT) — Financial statements
Income statement, balance sheet, and cash flow for Health Catalyst, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 311↑1.5% | 307↑3.6% | 296↑7.1% | 276↑14.2% | 242 | |
| Cost of Revenue | 207↑24.8% | 166↑1.0% | 164↑14.7% | 143↑15.0% | 124 | |
| Gross Profit | 104↓26.0% | 141↑6.8% | 132↓1.0% | 133↑13.3% | 118 | |
| Operating Expenses | ||||||
| R&D Expenses | 50↓14.1% | 58↓20.2% | 73↓4.0% | 76↑20.6% | 63 | |
| General & Administrative Expenses | 50↓12.8% | 57↓25.8% | 77↑24.1% | 62↓28.2% | 86 | |
| Selling & Marketing Expenses | 52↓3.5% | 54↓19.2% | 67↓23.1% | 88↑16.6% | 75 | |
| SG&A Expenses | 102↓8.2% | 111↓22.7% | 144↓3.6% | 149↓7.3% | 161 | |
| Other Expenses | -12↓127.9% | 41↓1.9% | 42↓12.6% | 48↑28.7% | 38 | |
| Operating Expenses | 140↓33.4% | 211↓18.6% | 259↓5.3% | 273↑4.6% | 261 | |
| Total Costs & Expenses | 347↓7.7% | 376↓11.0% | 423↑1.6% | 416↑8.0% | 386 | |
| Operating Results | ||||||
| Operating Income | -36↑48.3% | -70↑45.0% | -127↑9.4% | -140↑2.5% | -144 | |
| Depreciation & Amortization | 51↑21.9% | 41↓1.9% | 42↓18.1% | 52↑25.3% | 41 | |
| EBITDA | 14↑235.1% | -11↑84.4% | -68↑17.7% | -83↑18.5% | -102 | |
| EBIT | -36↑30.7% | -52↑52.9% | -111↑17.8% | -134↑5.8% | -143 | |
| Interest & Other Income | ||||||
| Net Interest Income | -9↓1089.8% | 0.90↓90.2% | 9↑686.5% | -2↑90.6% | -16 | |
| Interest Income | 8↓58.1% | 18↑9.7% | 16↑188.2% | 6↑584.4% | 0.83 | |
| Interest Expense | 16↓4.0% | 17↑134.5% | 7↑0.7% | 7↓58.2% | 17 | |
| Non-Operating Income | 0.00↑100.0% | -18↓8.1% | -16↓194.8% | -6↓550.4% | -0.86 | |
| Other Income / Expenses | -141↓22259.2% | 0.64↓93.0% | 9↑642.7% | -2↑89.8% | -16 | |
| Income Before Tax | -177↓156.3% | -69↑41.3% | -118↑16.9% | -142↑11.5% | -160 | |
| Income Tax Expense | 0.72↑115.0% | 0.33↓6.5% | 0.36↑108.3% | -4↑38.0% | -7 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -178↓156.1% | -70↑41.2% | -118↑14.0% | -137↑10.3% | -153 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -178↓156.1% | -70↑41.2% | -118↑14.0% | -137↑10.3% | -153 | |
| Bottom-Line Net Income | -178↓156.1% | -70↑41.2% | -118↑14.0% | -137↑10.3% | -153 | |
| EPS (Basic) | -2.55↓121.7% | -1.15↑45.0% | -2.09↑18.4% | -2.56↑20.7% | -3.23 | |
| EPS (Diluted) | -2.55↓121.7% | -1.15↑45.0% | -2.09↑17.7% | -2.54↑21.4% | -3.23 | |
| Weighted Average Shares | 70↑16.1% | 60↑6.7% | 56↑5.0% | 54↑13.1% | 47 | |
| Weighted Average Diluted Shares | 70↑16.1% | 60↑6.7% | 56↑4.3% | 54↑13.9% | 47 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.